Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation
Open Access
- 1 August 2021
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 336, 192-206
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Contamination of nanoparticles by endotoxin: evaluation of different test methodsParticle and Fibre Toxicology, 2012
- Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization LaboratoryIntegrative Biology, 2012
- Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisomeNanomedicine: Nanotechnology, Biology and Medicine, 2012
- In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticlesToxicology and Applied Pharmacology, 2010
- Present and future ofin vitroimmunotoxicology in drug developmentJournal of Immunotoxicology, 2010
- Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5aImmunology Letters, 2010
- Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groupsBiomaterials, 2009
- Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host responseJournal of The Royal Society Interface, 2009
- Efficacy of Simple Short-Term in Vitro Assays for Predicting the Potential of Metal Oxide Nanoparticles to Cause Pulmonary InflammationEnvironmental Health Perspectives, 2009
- Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cellsSurgery, 2004